The CCBCF is pleased to announce funding for the Hawkins Lab at the Hospital for Sick Children in Toronto, Ontario. Lead by Dr. Cynthia Hawkins, funds provided will be used to supplement their most recent project to find therapeutic agents for DIPG by learning more about the H3K27M mutation. 

Exploring the interactome of H3K27M to find therapeutic targets for DIPG

Dr. Hawkins and her team are world leaders in the field pediatric brain cancer research. Their work has uncovered important clues that has lead the us closer to a cure, learn more: http://pubmedcentralcanada.ca/pmcc/articles/PMC3997489